RBI
India's $32 Billion Forex Drive Yet to Deliver Stronger Rupee Support

Lumic
about 2 months ago
India's $32 Billion Forex Drive Yet to Deliver Stronger Rupee Support
India has attracted $32 billion under RBI forex measures to strengthen external finances.
Inflows have improved liquidity buffers but have not meaningfully strengthened the rupee.
RBI says government cash balances and interventions have tempered the currency impact.
LUMIC INSIGHT
Currency strength depends on more than foreign inflows.
This 'Insights' piece delves into India's recent $32 billion foreign exchange (forex) initiative spearheaded by the RBI. While these measures aimed to bolster the rupee and strengthen the country's external finances, the currency's performance has not seen a significant uptick. We explore how, despite improving liquidity buffers through measures like FCNR deposits and dollar inflows, the INR hasn't gained the expected strength. The Reserve Bank of India points to factors such as government cash balances and its own market interventions as reasons tempering the direct impact of these forex reserves. Understand the nuances of India's currency dynamics and balance of payments in this detailed analysis.
More in RBI

Lumic
21 days ago
RBI
Bank Credit Surges 20% as Industry and Services Borrowing Accelerates
- Bank credit to industry grew 20% in July, sharply up from 6.5% from the last year
- Services credit jumped 22.9%, led by NBFCs, trade and commercial real estate sectors
- Infrastructure, engineering, metals and chemicals saw strong credit expansion in July
LUMIC INSIGHT
Banking Stocks likely to continue their outperformance
Moneycontrol·

Lumic
22 days ago
RBI
RBI Steps In Again as Oil and Fed Bets Put Rupee Under Pressure
- RBI stepped in again as the rupee weakened to 95.60 per dollar amid rising oil prices
- Brent crude climbed above $90, adding pressure as markets raised Fed hike expectations
- RBI intervention helped keep the rupee near 95.44 despite stronger external headwinds
LUMIC INSIGHT
Weak rupee usually benefits IT & Pharma stocks.
Business Standard·